drs. M. Beijert

m.beijert umcg.nl


  1. 2019
  2. Bromberg, J. E. C., Issa, S., Bakunina, K., Minnema, M. C., Seute, T., Durian, M., ... Doorduijn, J. K. (2019). Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. Lancet Oncology, 20(2), 216-228. https://doi.org/10.1016/S1470-2045(18)30747-2
  3. Rigter, L. S., Schaapveld, M., Janus, C. P. M., Krol, A. D. G., van der Maazen, R. W. M., Roesink, J., ... van Leerdam, M. E. (2019). Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer. Cancer medicine, 8(1), 190-199. https://doi.org/10.1002/cam4.1922
  4. 2018
  5. 2017
  6. 2016
  7. 2015
  8. Schaapveld, M., Aleman, B. M. P., van Eggermond, A. M., Janus, C. P. M., Krol, A. D. G., van der Maazen, R. W. M., ... van Leeuwen, F. E. (2015). Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. New England Journal of Medicine, 373(26), 2499-2511. https://doi.org/10.1056/NEJMoa1505949
  9. 2013
  10. Krijgsman, O., Gonzalez, P., Ponz, O. B., Roemer, M. G. M., Slot, S., Broeks, A., ... de Jongi, D. (2013). Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features. Haematologica, 98(12), 1921-1929. https://doi.org/10.3324/haematol.2013.085118
  11. 2012
  12. Koning, C. C. E., Blank, L. E. C. M., Koedooder, C., van Os, R. M., van de Kar, M., Jansen, E., ... Pieters, B. R. (2012). Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors. Annals of Oncology, 23(11), 2948-2953. https://doi.org/10.1093/annonc/mds126

ID: 440371